Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2015 1
2017 2
2018 1
2020 1
2021 1
2022 2
2023 4
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson Disease.
Pürner D, Hormozi M, Weiß D, Barbe MT, Jergas H, Prell T, Gülke E, Pötter-Nerger M, Falkenburger B, Klingelhöfer L, Gutsmiedl PK, Haslinger B, Jochim AM, Wolff A, Schröter N, Rijntjes M, van Riesen C, Scheller U, Wolz M, Amouzandeh A, Ebersbach G, Gruber D, Kohl Z, Maetzler W, Paschen S, Pérez-González P, Rozanski V, Schwarz J, Südmeyer M, Torka E, Wesbuer S, Bornmann S, Flöel A, Ip CW, Krause P, Kühn AA, Csoti I, Herting B, van de Loo S, Basheer AA, Liszka R, Jost WH, Koschel J, Haller B, Lingor P. Pürner D, et al. Among authors: liszka r. Neurology. 2023 Nov 21;101(21):e2078-e2093. doi: 10.1212/WNL.0000000000207858. Epub 2023 Nov 1. Neurology. 2023. PMID: 37914414 Free PMC article.
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.
Sosero YL, Bandres-Ciga S, Ferwerda B, Tocino MTP, Belloso DR, Gómez-Garre P, Faouzi J, Taba P, Pavelka L, Marques TM, Gomes CPC, Kolodkin A, May P, Milanowski LM, Wszolek ZK, Uitti RJ, Heutink P, van Hilten JJ, Simon DK, Eberly S, Alvarez I, Krohn L, Yu E, Freeman K, Rudakou U, Ruskey JA, Asayesh F, Menéndez-Gonzàlez M, Pastor P, Ross OA, Krüger R; NCER‐PD Consortium; Corvol JC, Koks S, Mir P, De Bie RMA, Iwaki H, Gan-Or Z; International Parkinson's Disease Genomic Consortium. Sosero YL, et al. Mov Disord. 2024 Oct;39(10):1773-1783. doi: 10.1002/mds.29960. Epub 2024 Aug 12. Mov Disord. 2024. PMID: 39132902
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
Odin P, Ray Chaudhuri K, Slevin JT, Volkmann J, Dietrichs E, Martinez-Martin P, Krauss JK, Henriksen T, Katzenschlager R, Antonini A, Rascol O, Poewe W; National Steering Committees. Odin P, et al. Parkinsonism Relat Disord. 2015 Oct;21(10):1133-44. doi: 10.1016/j.parkreldis.2015.07.020. Epub 2015 Jul 23. Parkinsonism Relat Disord. 2015. PMID: 26233582 Free article. Review.
16 results